Joshi, Shilpy
Freudenberg, Johannes M.
Singh, Jennifer M.
Jordan, William T.
Felton, Leigh
Dixon, Susan
Paff, Melanie
Theodore, Dickens
Walker, Jill
Funding for this research was provided by:
GSK (209348)
Article History
Received: 25 June 2025
Accepted: 12 September 2025
First Online: 3 October 2025
Declarations
:
: S Joshi, JM Freudenberg, WM Jordan, JM Singh, L Felton, S Dixon, M Paff, D Theodore, and J Walker are employed by GSK and hold financial equities in GSK. S Joshi holds an international patent: WO2020/239478 A1. JM Singh holds two US patents: #11,021,502 and #11,873,312. L Felton, S Dixon, and D Theodore hold provisional US patents.
: Both trials were conducted in accordance with the Declaration of Helsinki, Council for International Organizations of Medical Sciences, International Ethical Guidelines for Biomedical Research Involving Human Subjects, Good Clinical Practice guidelines of the International Council for Harmonisation, and all applicable laws and regulations in participating countries. Independent Data Monitoring Committees reviewed unblinded study data. All participants were required to give written informed consent prior to enrollment.